Live · 05 Oct 2026 SPX 7,722.72 +0.73% NDX 30,807.93 +1.00% VIX 15.31 -6.59% GOLD 4,159.70 -0.06% CL 90.29 -0.90% BTC 85,502.57 +0.87%
NAS100 30,808 +1.00% S&P 7,723 +0.73% GOLD $4,160 −0.06% BTC $85,503 +0.87% VIX 15.31 −6.59% live tape · as of 05:02 UTC
The Screen · Healthcare

ALPS Group Inc

ALPS · USD · Market cap $67M

PASS · Titan Ethical · score 70.0
0.40 USD

Screen close, 2026-09-21 · not a live quote
Last reviewed 14 days ago

Screened 2026-09-21 · the tape above runs as of 05:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y

What this means: price 0.40 against the desk's fair-value range, over the last year.

Current read
Accumulation ?
Screened · screened 2026-09-21
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical passes the values gate
Price0.40 USD
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Accumulation0.40+0.0% to today ✓
2026-09-21Read Markup0.40+0.0% to today ✓
2026-08-21Read Markdown0.33+22.0% to today
2026-07-02Read Distribution0.72-44.8% to today ✓

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

ALPS Group Inc holds its Accumulation at $0.40. Consolidating, no directional conviction, held for 56 days.

As held on the ledger · 2026-09-21
PhaseAccumulation
Quantitative stateConsolidating, no directional conviction, held for 56 days
Price at the screen$0.40
ValuationN/A trailing · N/A forward price to earnings
Values screenPASS · score 70.0
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 13.48% Below 33% Interest-bearing debt is just 13.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 5.11% Below 49% Money owed to the company is 5.1% of assets, under the 49% limit. Pass
Revenue purity 0.00% Below 5% Only 0.0% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

ALPS clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 13%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-02 Accumulation · changed $0.40 +0.0% Entry 8

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 16%.

2026-09-21 Markup · changed $0.40 +21.9% Entry 7

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 21.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 16%.

2026-08-21 Markdown · changed $0.33 -34.4% Entry 6

The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 34.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 16%.

2026-07-21 Distribution $0.50 -31.0% Entry 5

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 31.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 16%.

2026-07-18 Distribution $0.72 +0.0% Entry 4

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 16%.

2026-07-17 Distribution $0.72 +0.0% Entry 3

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 16%.

2026-07-03 Distribution $0.72 +0.0% Entry 2

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.

2026-07-02 Distribution $0.72 Entry 1

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on ALPS

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in ALPS's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $0.83 -15.1% · $849 -15.1%
2 months $1.00 -29.6% · $705 -29.6%
3 months $1.17 -40.0% · $600 -40.0%
6 months $1.03 -31.6% · $684 -31.6%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever ALPS does next, these words stay.

ALPS Group Inc · ALPS · Accumulation · $0.40
Recorded 2026-09-21 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.